Chair of the Sutherland’s Medical Devices practice team, Kevin King has deep experience in intellectual property issues in the medical device, drug delivery and other biomedical industries. He counsels clients in the medical device industry with intellectual property issues, including patents, licensing, and trade secrets. Kevin works closely with start-up companies to help with the critical early development stages of intellectual property. He focuses on domestic and international patent prosecution and intellectual property counseling for chemical, mechanical and biomedical technologies, including implantable drug delivery systems, biological tissue grafts, surgical adhesives, pharmaceutical formulations, surgical tools, diagnostic sensors, vascular closures, and microneedles. He also performs related work for a number of renowned research universities, as well as for cardiologists, urologists, and other entrepreneurs.
Kevin leveraged his substantive understanding of intellectual property issues to help one medical device company build a portfolio of more than 150 domestic and foreign patents and applications that protects the client’s pioneering technology for a new generation of implantable drug delivery and biosensing devices. He has helped guide patent strategy in matters ranging from protecting a novel urological drug delivery device platform to providing patent clearance opinions for several different cardiovascular medical technologies. Kevin also successfully challenged a number of competitor patents for his clients through U.S. Patent and Trademark Office re-examination proceedings.
Sutherland undertakes IP due diligence and freedom-to-operate analysis in $22 million purchase of cardiovascular products company.
Sutherland conducted IP counseling and due diligence for our client in a $22 million acquisition of surgical-products company and provided ongoing patent prosecution related to the target company's laser-based products for treating angina patients.
Sutherland helps client build portfolio of 150 patents to protect pioneering implantable device.
We provided patent prosecution and IP counseling services to help our client build a portfolio of more than 150 domestic and foreign patents and applications to protect a new generation of implantable drug delivery devices and biosensors.
Sutherland represents university in patenting innovations in microneedles for ocular and transdermal drug delivery.
Sutherland advised an internationally recognized research university in patenting a microneedle technology for transdermal and ocular drug delivery and diagnostic fluid sampling.
Awards and Rankings
Named to The Best Lawyers in America in the area of patent law (2013-2014)
Selected for inclusion in Georgia Super Lawyers® “Rising Stars” (2005-2006)
Selected for inclusion in IP Stars® by Managing Intellectual Property (2013)
Member, Intellectual Property Law Section, American Bar Association
Member, Intellectual Property Law Section, State Bar of Georgia
Member, Georgia Biotechnology Industry Organization (GaBio)